Adient (NYSE:ADNT – Get Free Report) had its price objective lowered by investment analysts at UBS Group from $20.00 to $13.00 in a note issued to investors on Thursday,Benzinga reports. The firm currently has a “neutral” rating on the stock. UBS Group’s price objective points to a potential upside of 24.94% from the stock’s previous close.
A number of other brokerages have also recently commented on ADNT. Barclays dropped their price objective on shares of Adient from $24.00 to $21.00 and set an “equal weight” rating on the stock in a research note on Wednesday, January 22nd. Bank of America lowered shares of Adient from a “neutral” rating to an “underperform” rating and dropped their price target for the company from $24.00 to $18.00 in a research report on Tuesday, March 4th. Morgan Stanley decreased their price objective on shares of Adient from $19.00 to $17.00 and set an “underweight” rating for the company in a research report on Monday, March 3rd. StockNews.com raised shares of Adient from a “hold” rating to a “buy” rating in a research note on Tuesday, April 1st. Finally, JPMorgan Chase & Co. cut their price target on Adient from $24.00 to $21.00 and set a “neutral” rating for the company in a research note on Monday, January 27th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $20.00.
Read Our Latest Report on ADNT
Adient Trading Down 1.7 %
Adient (NYSE:ADNT – Get Free Report) last issued its quarterly earnings data on Tuesday, January 28th. The company reported $0.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.05). Adient had a negative net margin of 0.01% and a positive return on equity of 6.94%. During the same period last year, the firm posted $0.31 earnings per share. Research analysts forecast that Adient will post 1.76 earnings per share for the current year.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Pzena Investment Management LLC increased its stake in Adient by 28.5% during the 4th quarter. Pzena Investment Management LLC now owns 3,629,452 shares of the company’s stock worth $62,535,000 after buying an additional 803,961 shares in the last quarter. Arrowstreet Capital Limited Partnership purchased a new stake in shares of Adient during the fourth quarter worth approximately $11,395,000. Millennium Management LLC raised its stake in Adient by 2,039.0% in the 4th quarter. Millennium Management LLC now owns 610,312 shares of the company’s stock valued at $10,516,000 after purchasing an additional 581,779 shares during the last quarter. HITE Hedge Asset Management LLC raised its stake in Adient by 122.4% in the 4th quarter. HITE Hedge Asset Management LLC now owns 816,286 shares of the company’s stock valued at $14,065,000 after purchasing an additional 449,272 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in Adient by 96.5% in the 4th quarter. JPMorgan Chase & Co. now owns 802,540 shares of the company’s stock valued at $13,828,000 after purchasing an additional 394,111 shares in the last quarter. 92.44% of the stock is owned by hedge funds and other institutional investors.
Adient Company Profile
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Featured Stories
- Five stocks we like better than Adient
- The 3 Best Blue-Chip Stocks to Buy Now
- JPMorgan is a Buy, if You Can Handle The Volatility
- How Technical Indicators Can Help You Find Oversold Stocks
- United States Steel’s Crash: An Unmissable Buying Opportunity
- What Are Dividend Champions? How to Invest in the Champions
- Rocket Lab Stock: Weathering the Storm, Time for a Comeback?
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.